LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.78 | 771.67 | 1457 | 3499 | 0.4163 | 0.3383 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.55 | 771.67 | 1792 | 6829 | 0.2624 | 0.3071 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.00 | 771.67 | 1400 | 1585 | 0.8830 | 0.7743 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.55 | 771.67 | 1429 | 3196 | 0.4470 | 0.3505 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.67 | 771.67 | 1617 | 5155 | 0.3136 | 0.3099 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.33 | 771.67 | 1764 | 6392 | 0.2759 | 0.3113 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 6.94 | 771.67 | 1040 | 1045 | 0.9951 | 0.9777 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.78 | 771.67 | 1321 | 1459 | 0.9050 | 0.7942 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.66 | 771.67 | 1430 | 2141 | 0.6678 | 0.5203 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.33 | 771.67 | 1471 | 2939 | 0.5005 | 0.3971 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.22 | 771.67 | 1509 | 4299 | 0.3510 | 0.3108 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.44 | 771.67 | 1558 | 4738 | 0.3288 | 0.3078 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 44.89 | 771.67 | 1658 | 5541 | 0.2992 | 0.3085 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.11 | 771.67 | 1699 | 5941 | 0.2860 | 0.3074 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 2.49 | 771.67 | 816 | 867 | 0.9404 | 0.3909 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 4.71 | 771.67 | 936 | 956 | 0.9787 | 0.8656 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 9.16 | 771.67 | 1099 | 1138 | 0.9653 | 0.8780 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.56 | 771.67 | 1213 | 1280 | 0.9472 | 0.8569 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.22 | 771.67 | 1420 | 1741 | 0.8155 | 0.6810 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.44 | 771.67 | 1437 | 1910 | 0.7520 | 0.6085 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.89 | 771.67 | 1457 | 2397 | 0.6077 | 0.4749 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.11 | 771.67 | 1425 | 2675 | 0.5327 | 0.4077 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.00 | 771.67 | 1504 | 3884 | 0.3872 | 0.3314 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.99 | 771.67 | 1986 | 7690 | 0.2583 | 0.3298 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 771.67 | 1799 | 7256 | 0.2479 | 0.2993 | MN20160304_L01 | N22 |